Nuclear factor-κ B repression in antiinflammation and immunosuppression by glucocorticoids

Trends in Endocrinology and Metabolism

Volumn 8, Issue 4, 1997, Pages 152-157

  Van Der Burg, Bart ^a   Liden, Johan ^b   Okret, Sam ^b   Delaunay, Franck ^b   Wissink, Sacha ^a   Van Der Saag, Paul T ^a   Gustafsson, Jan Åke ^b  

^a HUBRECHT INSTITUTE   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

GENE REPRESSION; HORMONAL REGULATION; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0030988726     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(97)00006-4     Document Type: Review

References (45)

1. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science. 270:1995;286-290.
2. Aziz KE, Wakefield D Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone. Cell Immunol. 167:1996;79-85.
3. Baeuerle PA, Henkel T Function and activation of NF-κB in the immune system. Annu Rev Immunol. 12:1994;141-179.
4. Barnes PJ Molecular mechanisms of antiasthma therapy. Ann Med. 27:1995;531-535.
5. Barnes PJ, Adcock I Anti-inflammatory action of steroids: molecular mechanism. Trends Pharmacol Sci. 12:1993;436-441.
6. Bendrups A, Hilton A, Meager A, Hamilton JA Reduction of tumor necrosis factor alpha and interleukin-1-beta levels in human synovial tissue by interleukin-4 and glucocorticoid. Rheumatol Int. 12:1993;217-220.
7. Blomhoff HK, Smeland EB: 1994. Role of retinoids in the normal hematopoiesis and the immune system. In Blomhoff R, ed. Vitamin A in Health and Disease. New York, Marcel Dekker; pp 451-484.
8. Brand K, Page S, Rogler Get al. Activated transcription factor nuclear factor-kappa-B is present in the atherosclerotic lesion. J Clin Invest. 97:1996;1715-1722.
9. Brostjan C, Anrather J, Csizmadia Vet al. Glucocorticoid-mediated repression of NFκB activity in endothelial cells does not involve induction of IκBα synthesis. J Biol Chem. 271:1996;19,612-19,616.
10. Caldenhoven E, Liden J, Wissink Set al. Negative crosstalk between RelA and the glucocorticoid receptor: a possible mechanism for the anti-inflammatory action of glucocorticoids. Mol Endocrinol. 9:1995;401-412.
11. Chen J-Y, Penco S, Ostrowski Jet al. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14:1995;1187-1197.
12. Collart MA, Baeuerle P, Vassalli P Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol. 10:1990;1498-1506.
13. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA. 89:1992;9991-9995.
14. Cutolo M, Sulli A, Barone A, Seriolo B, Accardo S The role of androgens in the pathophysiology of rheumatoid arthritis. Fundam Clin Immunol. 3:1995;9-18.
15. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science. 249:1990;1266-1272.
16. Fanjul A, Dawson MI, Hobbs PDet al. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature. 372:1994;107-111.
17. Geller DA, Nussler AK, Disilvio Met al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthetase in hepatocytes. Proc Natl Acad Sci USA. 90:1993;522-526.
18. Gilbert RS, Herschman HR Macrophage nitric oxide synthetase is a glucocorticoid-inhibitable primary response gene in 3T3 cells. J Cell Physiol. 157:1993;128-132.
19. Gronemeyer H, Laudet V Transcription factors 3: nuclear receptors. Protein Profile. 2:1995;1173-1308.
20. Grossman CJ: 1991. Immunoendocrinology. In Greenspan FS, ed. Basic and Clinical Endocrinology. Norwalk, CT, Appleton and Lange, pp 40-52.
21. Harant H, Demartin R, Andrew PJ, Foglar E, Dittrich C, Lindley IJD Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor-alpha involves the transcription factor Nf-Kappa-B. J Biol Chem. 271:1996;26,954-26,961.
22. Heck S, Kullmann M, Gast Aet al. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13:1994;4087-4095.
23. Jonat C, Rahmsdorf HJ, Park KKet al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62:1990;1189-1204.
24. Kalkhoven E, Wissink S, van der Saag PT, van der Burg B Negative interaction between the RelA(p65) subunit of NF-κB and the progesterone receptor. J Biol Chem. 271:1996;6217-6224.
25. Kato M, Schleimer RP Antiinflammatory steroids inhibit granulocyte/macrophage colony-stimulating factor production by human lung tissue. Lung. 172:1994;113-124.
26. Kelly RW Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocr Rev. 15:1994;684-706.
27. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Förstermann U Glucocorticoids inhibit the induction of nitric oxide synthetase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol. 49:1996;15-21.
28. Marok R, Winyard PG, Coumbe Aet al. Activation of the transcription factor nuclear factor-kappa-B in human inflamed synovial tissue. Arthritis Rheum. 39:1996;583-591.
29. Mehindate K, Aldaccak R, Schall TJ, Mourad W Induction of chemokine gene expression by major histocompatibility complex class II ligands in human fibroblast-like synoviocytes- differential regulation by interleukin-4 and dexamethasone. J Biol Chem. 269:1994;32,063-32,069.
30. Mukaida JK, Morita M, Ishikawa Yet al. Novel mechanism of glucocorticoid-mediated gene repression. J Biol Chem. 269:1994;13,289-13,295.
31. Neurath MF, Petterson S, Meyer zum Büschenfelde KH, Strober W Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med. 2:1996;998-1004.
32. Ohtsuka T, Kubota A, Hirano Tet al. Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-κB activation. J Biol Chem. 271:1996;1651-1659.
33. Pfahl M Nuclear receptor/AP-1 interaction. Endocr Rev. 14:1993;651-658.
34. Ray A, Prefontaine KE Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappaB and the glucocorticoid receptor. Proc Natl Acad Sci USA. 91:1994;752-756.
35. Ray A, LaForge KS, Sehgal PB On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer; TATA box, and RNA start site (INR motif) occlusion. Mol Cell Biol. 10:1990;5736-5746.
36. Ray A, Prefontaine KE, Ray P Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem. 269:1994;12,940-12,946.
37. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol. 15:1995;943-953.
38. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Role of IκBα in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286.
39. Siebenlist U, Franzoso G, Brown K Structure, regulation and function of NF-κB. Annu Rev Cell Biol. 10:1994;405-455.
40. Stein B, Yang MX Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBP. Mol Cell Biol. 15:1995;4971-4979.
41. Truss M, Beato M Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev. 14:1993;459-479.
42. Vacca A, Fellini MP, Marinotti Set al. Glucocorticoid receptor-mediated suppression of the interleukin-2 gene expression through impairment of the cooperativity between nuclear factor of activated T-cells and the AP-1 enhancer elements. J Exp Med. 175:1992;637-646.
43. Van de Stolpe A, Caldenhoven E, Raaijmakers JAM, van der Saag PT, Koenderman L Glucocorticoid-mediated repression of inter-cellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol. 8:1993;340-347.
44. Van de Stolpe A, Caldenhoven E, Stade BGet al. 12-O-Tetradecanoylphorbol-13-acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. J Biol Chem. 269:1994;6185-6192.
45. Yang-Yen HF, Chambard JC, Sun YLet al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 62:1990;1205-1215.